Stanford University
Showing 481-500 of 829 Results
-
Sidhartha Sinha
Assistant Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsThere are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:
(1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;
(2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain). -
Tammy Lisa Sirich
Assistant Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI conduct translational research focused on uremia and dialysis. I use mass spectrometry to conduct studies testing ways to reduce levels of solutes and examining the contribution of uremic solutes to illness.
-
Davud Sirjani, MD
Clinical Professor, Otolaryngology (Head and Neck Surgery)
Current Research and Scholarly InterestsInnovation of devices to improve the quality of life of patients with advanced head and neck cancers, minimal invasive parotid surgery, surgical simulation, flap reconstruction of large head and neck defects to restore cosmesis and function (speech, swallowing), stem cell recovery of radiation induced salivary damage, and salivary gland cancer biology
-
David Sirkin
Lecturer
BioDavid Sirkin is a Research Associate at Stanford University's Center for Design Research, where he focuses on design methodology, as well as the design of physical interactions between humans and robots, and autonomous vehicles and their interfaces. He is also a Lecturer in Electrical Engineering, where he teaches interactive device design. David frequently collaborates with, and consults for, local Silicon Valley and global technology companies including Siemens, SAP and Microsoft Research. He grew up in Florida, near the Everglades, and in Maine, near the lobsters.
-
Shyam Mohan Sivasankar
Clinical Assistant Professor, Emergency Medicine
BioMy interests lie in the intersection of Medicine and Media, Global Pediatric Emergency Medicine Education, Child Abuse Pediatrics, and in Medical Student Education.
-
Nariman Skakov
Current Research and Scholarly InterestsLate Modernist Experimentation and Stalinist Central Asia
-
Kelley M. Skeff, MD, PhD
George DeForest Barnett Professor of Medicine
Current Research and Scholarly InterestsDevelopment and evaluation of improved teaching methods; assessment of teacher's attitudes toward their teaching role; study of clinical teaching; evaluation of alternative methods of learning in clinical clerkships (e.g. computer assisted instruction, video tape review, etc.).
-
Georgios Skiniotis
Professor of Molecular and Cellular Physiology, of Structural Biology and of Photon Science
BioThe Skiniotis laboratory seeks to resolve structural and mechanistic questions underlying biological processes that are central to cellular physiology. Our investigations employ primarily cryo-electron microscopy (cryoEM) and 3D reconstruction techniques complemented by biochemistry, biophysics and simulation methods to obtain a dynamic view into the macromolecular complexes carrying out these processes. The main theme in the lab is the structural biology of cell surface receptors that mediate intracellular signaling and communication. Our current main focus is the exploration of the mechanisms responsible for transmembrane signal instigation in cytokine receptors and G protein coupled receptor (GPCR) complexes.
-
Eila C. Skinner
Thomas A. Stamey Research Professor of Urology
Current Research and Scholarly InterestsMy research focuses on outcomes in the treatment of muscle invasive and high-grade non-muscle invasive bladder cancer. This includes identifying markers of prognosis, predictive markers for response to surgery and chemotherapy, and working toward an individualized, multidisciplinary approach to disease management. I have also focused on optimizing the use of lower urinary tract reconstruction in patients undergoing cystectomy, and developing interventions to improve patient quality of life.
-
Lawrie Skinner
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
BioDr Skinner is a Board certified therapeutic medical physicist with interests in novel 3D printed devices and a research background in synchrotron x-ray scattering, neutron scattering, molecular dynamics and Monte Carlo computational modelling.
-
Stephen Skirboll
Associate Professor of Neurosurgery
On Leave from 06/24/2024 To 09/06/2024Current Research and Scholarly InterestsMy research focuses on screening strategies to identify and characterize cancer stem cells (CSCs) in human gliomas. We are pursuing this in several ways: 1) a novel colony-forming antibody live cell array to identify distinct CSC surface phenotypes, 2) RNAi screens to identify kinases critical for CSC tumorigenicity, 3) high throughput small molecule and chemical screens to identify compounds that selectively kill or target CSCs, and 4) identifying CSCs using the tumor specific EGFRvIII
